Key result
CACNA1A mutations were associated with epilepsy, with compound heterozygous mutations occurring at a higher frequency than in controls and severe phenotypes linked to pore region mutations.
Why the study?
To determine the relationship between CACNA1A mutations and epilepsies, and the role of molecular sub-regions on phenotypic heterogeneity.
Case-Control (n=764)
Yes
CACNA1A mutations are potentially associated with pure epilepsy, with the severity of clinical phenotypes linked to the molecular sub-region of the mutations.
Answers are grounded in this paper and cite their sources.
CACNA1A variants may inform genetic evaluation in unexplained epilepsy; hypothesis-generating for pore-region severity links pending replication.
Purpose Previously, mutations in the voltage-gated calcium channel subunit alpha1 A ( CACNA1A ) gene have been reported to be associated with paroxysmal disorders, typically as episodic ataxia type 2. To determine the relationship between CACNA1A and epilepsies and the role of molecular sub-regional on the phenotypic heterogeneity. Methods Trio-based whole-exome sequencing was performed in 318 cases with partial epilepsy and 150 cases with generalized epilepsy. We then reviewed all previously reported CACNA1A mutations and analyzed the genotype-phenotype correlations with molecular sub-regional implications. Results We identified 12 CACNA1A mutations in ten unrelated cases of epilepsy, including four de novo null mutations (c.2963_2964insG/p.Gly989Argfs*78, c.3089 + 1G > A, c.4755 + 1G > T, and c.6340-1G > A), four de novo missense mutations (c.203G > T/p.Arg68Leu, c.3965G > A/p.Gly1322Glu, c.5032C > T/p.Arg1678Cys, and c.5393C > T/p.Ser1798Leu), and two pairs of compound heterozygous missense mutations (c.4891A > G/p.Ile1631Val& c.5978C > T/p.Pro1993Leu and c.3233C > T/p.Ser1078Leu&c.6061G > A/p.Glu2021Lys). The eight de novo mutations were evaluated as pathogenic or likely pathogenic mutations according to the criteria of American College of Medical Genetics and Genomics (ACMG). The frequencies of the compound heterozygous CACNA1A mutations identified in this cohort were significantly higher than that in the controls of East Asian and all populations ( P = 7.30 × 10 –4 , P = 2.53 × 10 –4 ). All of the ten cases were ultimately seizure-free after antiepileptic treatment, although frequent epileptic seizures were observed in four cases. Further analysis revealed that episodic ataxia type 2 (EA2) had a tendency of higher frequency of null mutations than epilepsies. The missense mutations in severe epileptic phenotypes were more frequently located in the pore region than those in milder epileptic phenotypes ( P = 1.67 × 10 –4 ); de novo mutations in the epilepsy with intellectual disability (ID) had a higher percentage than those in the epilepsy without ID ( P = 1.92 × 10 –3 ). Conclusion This study suggested that CACNA1A mutations were potentially associated with pure epilepsy and the spectrum of epileptic phenotypes potentially ranged from the mild form of epilepsies such as absence epilepsy or partial epilepsy, to the severe form of developmental epileptic encephalopathy. The clinical phenotypes variability is potentially associated with the molecular sub-regional of the mutations.
No takes yet. Share an insight, caveat, or question.
Li et al. (2022) conducted a case-control in Epilepsy (n=764). CACNA1A mutations vs. Healthy controls / no mutation was evaluated on Frequency of compound heterozygous CACNA1A mutations (p=7.30x10^-4). CACNA1A mutations were associated with epilepsy, with compound heterozygous mutations occurring at a higher frequency than in controls and severe phenotypes linked to pore region mutations.
Synapse has enriched 10 related papers. Consider them for comparative context: